IP Library Assignment 048819/0304
Patent Assignment
Reel/Frame 048819/0304

Assignment of Assignor's Interest

Recorded: 2019-04-08 Pages: 9
Assignors
KOSEC, GREGOR
Executed: 2019-03-29
FUJS, STEFAN
Executed: 2019-03-29
PETKOVIC, HRVOJE
Executed: 2019-03-29
Assignee
ACIES BIO D.O.O.
TEHNOLOSKI PARK 21, LJUBLJANA, 1000, SLOVENIA
Covered Property (1)
Phosphopantetheine Compounds Alone or in Combination with Hmg-Coa Reductase Inhibitors for Lowering Serum Cholesterol and Serum Triglicerides
Application: 15/539,340 →
Publication: US 2018/0214461
Related Assignments (7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 24, 2017
From: ACIES BIO D.O.O.
To: TM3 THERAPEUTICS B.V.
Reel/Frame 044583/0321 →
Assignment of Assignor's Interest Apr 8, 2019
From: SIBON, ODA CORNELIA MARIA; SRINIVASAN, BALAJI
To: RIJKSUNIVERSITEIT GRONINGEN; ACADEMISCH ZIEKENHUIS GRONINGEN
Reel/Frame 048819/0346 →
Change of Name Jan 27, 2020
From: TM3 THERAPEUTICS B.V.
To: COMET THERAPEUTICS B.V.
Reel/Frame 051624/0646 →
Assignment of Assignor's Interest Jan 27, 2020
From: COMET THERAPEUTICS B.V.
To: COMET THERAPEUTICS, INC.
Reel/Frame 051624/0654 →
Security Interest Mar 29, 2022
From: COMET THERAPEUTICS, INC.
To: KREOS CAPITAL VI (UK) LIMITED
Reel/Frame 059420/0866 →
Merger Oct 21, 2022
From: COMET THERAPEUTICS, INC.
To: VECTIVBIO COMET AG
Reel/Frame 061494/0528 →
Release of Security Interest Aug 24, 2023
From: KREOS CAPITAL VI (UK) LIMITED
To: VECTIVBIO COMET AG, F/K/A COMET THERAPEUTICS, INC.
Reel/Frame 064702/0362 →